NCT07074899

Brief Summary

This study is testing a new program designed to improve access to HIV testing and help connect people with available treatment or prevention services, based on their test result. The version of the program being tested in this study was designed for men who have sex with men (MSM) in Lima, Peru. The program has two main parts: 1) offering HIV testing at venues where people go for sex (called "sex-on-premises venues" or SOPVs), and 2) a text messaging app that shares useful information about HIV treatment/prevention; users can also message back to get support from a healthcare worker. Before doing this study, the researchers worked with community members and healthcare providers in the area to make sure that the HIV testing approach and mobile app were designed in a way that would be engaging and meet their needs. Every Thursday, Friday, and Saturday night during recruitment, the researchers will go to SOPVs popular among the MSM community in Lima and invite people to take an HIV test. On each recruitment date, they will offer one of the following HIV testing options:

  • The number and percentage of people who accept the program when offered
  • The number and percentage of participants who continue to engage with the mobile app after 3 months The study will also measure:
  • overall satisfaction with the app (based on a questionnaire sent at 3 months)
  • the number and percentage of participants who completed any form of HIV testing after 3 months
  • the number and percentage of participants who started HIV treatment (out of those with a positive HIV test)
  • the number and percentage of participants who started HIV pre-exposure prophylaxis, or "PrEP" (out of those with a negative HIV test) All follow-up will be done remotely. Participants will have the app for 3 months. After 3 months, they will get a follow-up questionnaire asking about their experiences with the program. The researchers will keep tracking results related to the HIV treatment/prevention services that people receive for up to 6 months.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
161

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 12, 2025

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

July 11, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 20, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

February 13, 2026

Status Verified

January 1, 2026

Enrollment Period

6 months

First QC Date

July 11, 2025

Last Update Submit

February 11, 2026

Conditions

Keywords

HIV self-testHIV preventionLatin AmericaLinkage to careCommunity-based HIV testing

Outcome Measures

Primary Outcomes (2)

  • Intervention Uptake

    The proportion of individuals who accept the intervention and enroll in the study among those who are approached and offered the intervention at the recruitment venue.

    30 minutes

  • Continued Engagement

    The proportion of participants who remain engaged with the mHealth component of the intervention over time, as indicated by having either 1) sent at least one text message reply (either responding directly to a programmed message or spontaneously messaging the provider team) or 2) logged into the WelTel online portal (or otherwise accessed the application content) within the previous 15 days.

    3 months

Secondary Outcomes (2)

  • HIV test completion

    3 months

  • User satisfaction

    3 months

Other Outcomes (7)

  • Linkage to HIV care

    3 months, 6 months

  • ART initiation

    3 months, 6 months

  • Linkage to HIV prevention

    3 months, 6 months

  • +4 more other outcomes

Study Arms (4)

Group 1 - Rapid Test

ACTIVE COMPARATOR

Participants will receive a rapid HIV test on-site at the time of enrollment.

Other: Multi-component HIV testing and linkage-to-services intervention

Group 2 - HIV Self-Test

ACTIVE COMPARATOR

Participants will be given an HIV self-test kit that they may use at the time and place of their choosing.

Other: Multi-component HIV testing and linkage-to-services intervention

Group 3 - Coupon

ACTIVE COMPARATOR

Participants will be given a coupon redeemable for a free future HIV test at a participating health center.

Other: Multi-component HIV testing and linkage-to-services intervention

Group 4 - "Choice"

ACTIVE COMPARATOR

Participants will be offered their choice of any one of the three HIV testing formats (rapid test, self-test, referral coupon).

Other: Multi-component HIV testing and linkage-to-services intervention

Interventions

The intervention includes two core components: 1. HIV testing offered at sex-on-premises-venues \[SOPVs\]; 2. mHealth-supported linkage to treatment/prevention services (enrollment in a two-way text messaging application adapted from the WelTel platform). In this trial, the specific format of HIV testing offered will differ according to intervention arm.

Also known as: Mercury
Group 1 - Rapid TestGroup 2 - HIV Self-TestGroup 3 - CouponGroup 4 - "Choice"

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥ 18 years
  • identifies as gay, bisexual, or other man who has sex with men (MSM)
  • attendance at the designated recruitment venue (SOPV) and is willing to receive the form HIV testing (i.e., intervention arm) offered on that recruitment date
  • has a mobile phone device and service capable of two-way SMS text messaging via the WelTel platform and is willing to send/receive text messages using their primary mobile phone number
  • able to read and write

You may not qualify if:

  • self-reports having a previous HIV diagnosis
  • cognitively or psychologically unable to participate in HIV testing (e.g. visibly intoxicated or self-reports being intoxicated)
  • unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Epicentro

Lima, Lima Province, Peru

Location

Via Libre

Lima, Lima Province, Peru

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Interventions

Mercury

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

Metals, HeavyElementsInorganic ChemicalsTransition ElementsMetals

Study Officials

  • Alexander J Lankowski, MD

    Fred Hutchinson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Intervention arm is randomly assigned at the level of the recruitment date.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate in VIDD

Study Record Dates

First Submitted

July 11, 2025

First Posted

July 20, 2025

Study Start

June 12, 2025

Primary Completion

December 13, 2025

Study Completion

March 31, 2026

Last Updated

February 13, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Deidentified data (baseline and follow-up surveys; primary, secondary, and exploratory outcomes) may be shared upon reasonable request by contacting the Principal Investigator.

Shared Documents
STUDY PROTOCOL, ICF

Locations